Latest Breaking News On - Modulator siponimod - Page 1 : comparemela.com

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announces.

Stanford schoolUnited statesNational harborUnited kingdomCity ofSan franciscoJohn mullalyChaim lebovitsBrainstorm cell therapeutics incCalifornia institute for regenerative medicineLifesci advisorsStanford school of medicineCalifornia pacific medical centerDrug administrationEuropean network to cureConsortium of multiple sclerosis centers